Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

11.1%

1 terminated/withdrawn out of 9 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 2 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 2

3(60.0%)

N/A

2(40.0%)

5Total

Phase 2(3)

N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT06480591Recruiting

Evaluation of the Pathobiology of CALR-mutated MPN Cells

Role: collaborator

NCT04906252Completed

Vfib by ECG or Echo During Cardiac Arrest

Role: collaborator

NCT01094132Phase 2Completed

Combined Digital Colposcopy Analysis to Improve Cervical Precancer and Cancer Detection

Role: collaborator

NCT03602729Not ApplicableUnknown

Comparison of Breastfeeding Teaching Intervention

Role: lead

NCT00041782Phase 2Terminated

Outpatient Treatment Of Deep Venous Thrombosis Using Subcutaneous Dalteparin (Fragmin) In Low Risk Cancer Patients

Role: collaborator

NCT02436616Unknown

microEEG for Neonatal Apnea, Bradycardia and Desaturation

Role: collaborator

NCT02406365Phase 2Unknown

Diagnostic Imaging Aid for Management of Cervical Lesions

Role: lead

NCT02406352Not ApplicableUnknown

Multispectral Digital Colposcope With Probe for Detection of Cervical Intraepithelial Neoplasia

Role: lead

NCT02406391Unknown

Adherence to Preventive Care for Cervical Cancer

Role: lead

All 9 trials loaded